Viewing Study NCT01707069


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT01707069
Status: COMPLETED
Last Update Posted: 2014-05-22
First Post: 2012-10-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid
Sponsor: Immunomic Therapeutics, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-10
Start Date Type: None
Primary Completion Date: 2013-05
Primary Completion Date Type: ACTUAL
Completion Date: 2013-06
Completion Date Type: ACTUAL
First Submit Date: 2012-10-10
First Submit QC Date: None
Study First Post Date: 2012-10-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-21
Last Update Post Date: 2014-05-22
Last Update Post Date Type: ESTIMATED